Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1Gastrointestinal 1Breast 1

Conditions

Breast Neoplasms 51Neoplasms 29Prostatic Neoplasms 28Head and Neck Neoplasms 15Lung Neoplasms 14Ovarian Neoplasms 9Pancreatic Neoplasms 8Urinary Bladder Neoplasms 6Sarcoma 6Oropharyngeal Neoplasms 6Hematologic Neoplasms 6Gastrointestinal Neoplasms 6Colorectal Neoplasms 6Uterine Cervical Neoplasms 5Rectal Neoplasms 5Neoplasm Metastasis 5Multiple Myeloma 5Esophageal Neoplasms 5Endometrial Neoplasms 5Depression 5Brain Neoplasms 5Squamous Cell Carcinoma of Head and Neck 4Polycystic Ovary Syndrome 4Motor Activity 4Melanoma 4Lymphoma 4Anxiety Disorders 4Stomach Neoplasms 3Pain 3Osteosarcoma 3

Interventions

Specimen Handling 2Genetic Testing 2Genetic Counseling 2Surveys and Questionnaires 1Standard of Care 1Interviews as Topic 1High-Throughput Nucleotide Sequencing 1Health Promotion 1Educational Status 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplastic Syndromes, Hereditary × Surveys and Questionnaires × 1 year × Clear all
NCT04763915 2025-09-19

IMPACT

Vanderbilt-Ingram Cancer Center

Phase NA Active not recruiting
720 enrolled
BreastGastrointestinalGenitourinaryGynecologic

Breast Neoplasms, Neoplastic Syndromes, Hereditary, Prostatic Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡